Company Profile

ESTABLISHED IN DECEMBER 1993, MEDICAMEN GROUP HAS VERTICALLY INTEGRATED FACILITIES IN TERMS OF R&D, APIS & FORMULATIONS. THE COMPANY IS NOW FOCUSING ON ONCOLOGY THERAPEUTICS & OTHER GENERICS WITH A VISION TO BE A GLOBAL LEADER IN ONCOLOGY GENERICS BY OFFERING AFFORDABLE MEDICINE WITH BEST-IN-CLASS QUALITY. APART FROM THE ABOVE, A SET OF 10 NON-ONCOLOGY FORMULATIONS IS ALSO BEING DETERMINED IN R & D FOR EU MARKET FILINGS. THE COMPANY HAS FIRM PLANS & INVESTMENTS FOR GLOBAL ROLLOUT OF ITS ONCOLOGY PRODUCTS IN USA, EUROPE, LATIN AMERICA, ASIA-PACIFIC, MENA ETC. THROUGH A COMBINATION OF OWN TEAM & ALLIANCE PARTNERS. INFRASTRUCTURE HIGHLIGHTS: R&D CENTRE APPROVED BY DEPARTMENT OF SCIENTIFIC & INDUSTRIAL RESEARCH(DSIR), AT BHIWADI, (RAJASTHAN, INDIA) FOR CARRYING OUT CHEMICAL, ANALYTICAL AND FORMULATION R&D. A STATE-OF-THE-ART API MANUFACTURING FACILITY UNDER ITS PARENT COMPANY, SHIVALIK RASAYAN LIMITED, AT DAHEJ (GUJARAT, INDIA) CONFORMING TO REQUIREMENTS OF USFDA EUGMP PICS